Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-01-07 @ 7:10 AM
Study NCT ID:
NCT00304551
Status:
COMPLETED
Last Update Posted:
2010-06-03
First Post:
2006-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)
Sponsor:
Chugai Pharmaceutical
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
JV19595
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Chugai Pharmaceutical
Old Organization:
Chugai Pharmaceutical